Paper36596387
Metabolic regulation of the proteasome under hypoxia by Poldip2 controls fibrotic signaling in vascular smooth muscle cells.
Paredes F and 7 others. Free Radic Biol Med, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Metabolic regulation of the proteasome under hypoxia by Poldip2 controls fibrotic signaling in vascular smooth muscle cells. Papers, record 36596387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36596387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proteasome Endopeptidase Complex | Major topic |
| Nuclear Proteins | Major topic |
| Humans | |
| Muscle, Smooth, Vascular | |
| Signal Transduction | |
| Hypoxia | |
| Connective Tissue Growth Factor |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 HL095070 | NHLBI NIH HHS | United States | P01HL095070 | PubMed and NIH |
Source NIH RePORTER
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27632054 | Hypoxia-increased expression of genes involved in inflammation, dedifferentiation, pro-fibrosis, and extracellular matrix remodeling of human bladder smooth muscle cells. | In Vitro Cell Dev Biol Anim | 2017 | https://conductscience.org/library/papers/27632054 | PubMed |
| 2 | 1840252 | Characterization of G1 and mitotic cyclins of budding yeast. | Cold Spring Harb Symp Quant Biol | 1991 | https://conductscience.org/library/papers/1840252 | PubMed |
| 3 | 28611671 | Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/28611671 | PubMed |
| 4 | 12450788 | The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? | Cancer Cell | 2002 | https://conductscience.org/library/papers/12450788 | PubMed |
| 5 | 27983601 | Transcriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27983601 | PubMed |
| 6 | 21123648 | Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. | Genes Dev | 2010 | https://conductscience.org/library/papers/21123648 | PubMed |
| 7 | 23947803 | HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). | Breast Cancer Res | 2013 | https://conductscience.org/library/papers/23947803 | PubMed |
| 8 | 31656131 | Mitochondrial Protein Poldip2 (Polymerase Delta Interacting Protein 2) Controls Vascular Smooth Muscle Differentiated Phenotype by O-Linked GlcNAc (N-Acetylglucosamine) Transferase-Dependent Inhibition of a Ubiquitin Proteasome System. | Circ Res | 2020 | https://conductscience.org/library/papers/31656131 | PubMed |
| 9 | 33358571 | Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity. | Trends Cancer | 2021 | https://conductscience.org/library/papers/33358571 | PubMed |
| 10 | 15315937 | Hypoxic induction of Ctgf is directly mediated by Hif-1. | Am J Physiol Renal Physiol | 2004 | https://conductscience.org/library/papers/15315937 | PubMed |
| 11 | 24288211 | CCN2 as a novel molecule supporting energy metabolism of chondrocytes. | J Cell Biochem | 2014 | https://conductscience.org/library/papers/24288211 | PubMed |
| 12 | 24797518 | Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts. | PLoS One | 2014 | https://conductscience.org/library/papers/24797518 | PubMed |
| 13 | 32791309 | Regulation of cellular communication network factor 2 (CCN2) in breast cancer cells via the cell-type dependent interplay between CCN2 and glycolysis. | J Oral Biosci | 2020 | https://conductscience.org/library/papers/32791309 | PubMed |
| 14 | 10837481 | Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10837481 | PubMed |
| 15 | 17237245 | Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. | Am J Physiol Heart Circ Physiol | 2007 | https://conductscience.org/library/papers/17237245 | PubMed |
| 16 | 11230108 | Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. | Circ Res | 2001 | https://conductscience.org/library/papers/11230108 | PubMed |
| 17 | 12081504 | Activation mechanism of CDK2: role of cyclin binding versus phosphorylation. | Biochemistry | 2002 | https://conductscience.org/library/papers/12081504 | PubMed |
| 18 | 21424084 | Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection. | Rom J Morphol Embryol | 2011 | https://conductscience.org/library/papers/21424084 | PubMed |
| 19 | 25647524 | GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner. | Oncol Rep | 2015 | https://conductscience.org/library/papers/25647524 | PubMed |
| 20 | 23825363 | Polymerase delta interacting protein 2 sustains vascular structure and function. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23825363 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42459705 | Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459705 | PubMed |
| 41840167 | Multi-omic analysis of the liver-breast axis reveals key hepatic mediators of breast cancer progression. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/41840167 | PubMed |
| 39054369 | Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39054369 | PubMed |
| 38994197 | Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38994197 | PubMed |
| 38731911 | Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731911 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36596387
GET https://conductscience.org/api/papers/v1/36596387/references?page=2